These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 34890841)

  • 1. Sphingosine 1-Phosphate Receptor 4 Promotes Nonalcoholic Steatohepatitis by Activating NLRP3 Inflammasome.
    Hong CH; Ko MS; Kim JH; Cho H; Lee CH; Yoon JE; Yun JY; Baek IJ; Jang JE; Lee SE; Cho YK; Baek JY; Oh SJ; Lee BY; Lim JS; Lee J; Hartig SM; Conde de la Rosa L; Garcia-Ruiz C; Lee KU; Fernández-Checa JC; Choi JW; Kim S; Koh EH
    Cell Mol Gastroenterol Hepatol; 2022; 13(3):925-947. PubMed ID: 34890841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice.
    Mridha AR; Wree A; Robertson AAB; Yeh MM; Johnson CD; Van Rooyen DM; Haczeyni F; Teoh NC; Savard C; Ioannou GN; Masters SL; Schroder K; Cooper MA; Feldstein AE; Farrell GC
    J Hepatol; 2017 May; 66(5):1037-1046. PubMed ID: 28167322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage Sphingosine 1-Phosphate Receptor 2 Blockade Attenuates Liver Inflammation and Fibrogenesis Triggered by NLRP3 Inflammasome.
    Hou L; Yang L; Chang N; Zhao X; Zhou X; Dong C; Liu F; Yang L; Li L
    Front Immunol; 2020; 11():1149. PubMed ID: 32695095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new mechanism of obeticholic acid on NASH treatment by inhibiting NLRP3 inflammasome activation in macrophage.
    Huang S; Wu Y; Zhao Z; Wu B; Sun K; Wang H; Qin L; Bai F; Leng Y; Tang W
    Metabolism; 2021 Jul; 120():154797. PubMed ID: 33984334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NLRP3 inflammasome activation is required for fibrosis development in NAFLD.
    Wree A; McGeough MD; Peña CA; Schlattjan M; Li H; Inzaugarat ME; Messer K; Canbay A; Hoffman HM; Feldstein AE
    J Mol Med (Berl); 2014 Oct; 92(10):1069-82. PubMed ID: 24861026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sphingomyelin synthase 1 mediates hepatocyte pyroptosis to trigger non-alcoholic steatohepatitis.
    Koh EH; Yoon JE; Ko MS; Leem J; Yun JY; Hong CH; Cho YK; Lee SE; Jang JE; Baek JY; Yoo HJ; Kim SJ; Sung CO; Lim JS; Jeong WI; Back SH; Baek IJ; Torres S; Solsona-Vilarrasa E; Conde de la Rosa L; Garcia-Ruiz C; Feldstein AE; Fernandez-Checa JC; Lee KU
    Gut; 2021 Oct; 70(10):1954-1964. PubMed ID: 33208407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacology of a Potent and Novel Inhibitor of the NOD-Like Receptor Pyrin Domain-Containing Protein 3 (NLRP3) Inflammasome that Attenuates Development of Nonalcoholic Steatohepatitis and Liver Fibrosis.
    Povero D; Lazic M; McBride C; Ambrus-Aikelin G; Stansfield R; Johnson CD; Santini AM; Pranadinata RF; McGeough MD; Stafford JA; Hoffman HM; Feldstein AE; Veal JM; Bain G
    J Pharmacol Exp Ther; 2023 Aug; 386(2):242-258. PubMed ID: 37308266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benzyl isothiocyanate ameliorates high-fat/cholesterol/cholic acid diet-induced nonalcoholic steatohepatitis through inhibiting cholesterol crystal-activated NLRP3 inflammasome in Kupffer cells.
    Chen HW; Yen CC; Kuo LL; Lo CW; Huang CS; Chen CC; Lii CK
    Toxicol Appl Pharmacol; 2020 Apr; 393():114941. PubMed ID: 32126212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of the NLRP3 inflammasome by CCl
    Vargas-Pozada EE; Ramos-Tovar E; Rodriguez-Callejas JD; Cardoso-Lezama I; Galindo-Gómez S; Gil-Becerril K; Vásquez-Garzón VR; Arellanes-Robledo J; Tsutsumi V; Villa-Treviño S; Muriel P
    Ann Hepatol; 2023; 28(1):100780. PubMed ID: 36309184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-specific Deletion of NLRP3 Inflammasome Identifies Myeloid Cells as Key Drivers of Liver Inflammation and Fibrosis in Murine Steatohepatitis.
    Kaufmann B; Kui L; Reca A; Leszczynska A; Kim AD; Booshehri LM; Wree A; Friess H; Hartmann D; Broderick L; Hoffman HM; Feldstein AE
    Cell Mol Gastroenterol Hepatol; 2022; 14(4):751-767. PubMed ID: 35787975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restraint stress promotes nonalcoholic steatohepatitis by regulating the farnesoid X receptor/NLRP3 signaling pathway.
    Yang F; Lv XT; Lin XL; Wang RH; Wang SM; Wang GE
    Acta Biochim Biophys Sin (Shanghai); 2023 Dec; 55(12):1961-1971. PubMed ID: 37997375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiolipin inhibitor ameliorates the non-alcoholic steatohepatitis through suppressing NLRP3 inflammasome activation.
    Liu J; Wang T; He K; Xu M; Gong JP
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):8158-8167. PubMed ID: 31599445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic high-fat diet induces galectin-3 and TLR4 to activate NLRP3 inflammasome in NASH.
    Li H; Cao Z; Wang L; Li J; Cheng X; Tang Y; Xing M; Yao P
    J Nutr Biochem; 2023 Feb; 112():109217. PubMed ID: 36402251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bee's honey attenuates non-alcoholic steatohepatitis-induced hepatic injury through the regulation of thioredoxin-interacting protein-NLRP3 inflammasome pathway.
    Xiao J; Liu Y; Xing F; Leung TM; Liong EC; Tipoe GL
    Eur J Nutr; 2016 Jun; 55(4):1465-77. PubMed ID: 26133299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of NLRP3 inflammasome by thioredoxin-interacting protein in mouse Kupffer cells as a regulatory mechanism for non-alcoholic fatty liver disease development.
    He K; Zhu X; Liu Y; Miao C; Wang T; Li P; Zhao L; Chen Y; Gong J; Cai C; Li J; Li S; Ruan XZ; Gong J
    Oncotarget; 2017 Jun; 8(23):37657-37672. PubMed ID: 28499273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sweroside Prevents Non-Alcoholic Steatohepatitis by Suppressing Activation of the NLRP3 Inflammasome.
    Yang G; Jang JH; Kim SW; Han SH; Ma KH; Jang JK; Kang HC; Cho YY; Lee HS; Lee JY
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32316419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NLRP3 inflammasome priming and activation in cholestatic liver injury via the sphingosine 1-phosphate/S1P receptor 2/Gα
    Hou L; Zhang Z; Yang L; Chang N; Zhao X; Zhou X; Yang L; Li L
    J Mol Med (Berl); 2021 Feb; 99(2):273-288. PubMed ID: 33388881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bax inhibitor-1 protects from nonalcoholic steatohepatitis by limiting inositol-requiring enzyme 1 alpha signaling in mice.
    Lebeaupin C; Vallée D; Rousseau D; Patouraux S; Bonnafous S; Adam G; Luciano F; Luci C; Anty R; Iannelli A; Marchetti S; Kroemer G; Lacas-Gervais S; Tran A; Gual P; Bailly-Maitre B
    Hepatology; 2018 Aug; 68(2):515-532. PubMed ID: 29457838
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Yen IC; Lin JC; Chen Y; Tu QW; Lee SY
    Am J Chin Med; 2020; 48(8):1859-1874. PubMed ID: 33308101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion of Thioredoxin-interacting protein ameliorates high fat diet-induced non-alcoholic steatohepatitis through modulation of Toll-like receptor 2-NLRP3-inflammasome axis: Histological and immunohistochemical study.
    Mohamed IN; Sarhan NR; Eladl MA; El-Remessy AB; El-Sherbiny M
    Acta Histochem; 2018 Apr; 120(3):242-254. PubMed ID: 29482933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.